• Gentamycin Sulfate in Resistance Research

  2026-10-05

  Gentamycin Sulfate is an aminoglycoside antibiotic used as a research reagent for bacterial protein synthesis and ribosome studies. A 2025 multicenter CREC study links gentamicin resistance with carbapenemase-encoding genes, but its findings do not establish treatment efficacy or clinical transmission risk.

• METTL9 and Cross-Kingdom Antifungal Defense

  2026-10-05

  The 2026 Cell Host & Microbe study identifies secreted intestinal METTL9 as a catalytic antifungal effector that methylates the Candida albicans zincophore PRA1 and disrupts fungal zinc acquisition. Its findings connect epithelial secretion, nutritional immunity, fungal colonization, and inflammatory bowel disease, while also suggesting a distinct framework for studying antifungal drug resistance beyond conventional drug targets.

• Chloramphenicol and Plasmid Selection: Evidence

  2026-10-04

  This source-grounded overview examines Chloramphenicol as a bacterial protein synthesis inhibitor and research reagent, then compares its conceptual relevance to recent evidence on carbapenemase-encoding genes in Enterobacter cloacae. It distinguishes supplier information from peer-reviewed findings and outlines limitations, including the absence of direct evidence linking chloramphenicol selection with the transmission patterns reported by Chen et al. (2025).

• NVP-BGJ398 Phosphate: FGFR3 Evidence Overview

  2026-10-03

  A source-grounded review of NVP-BGJ398 phosphate and FGFR3 pathway inhibition, centered on a 2024 mouse study of SLC26A2-related chondrodysplasia. It separates genetic, pharmacological, supplier-reported oncology, and translational evidence while emphasizing model-specific limitations and the absence of human efficacy data.

• Neomycin Sulfate: Assay Design Across Scales

  2026-10-02

  Neomycin sulfate is more than an aminoglycoside antibiotic: it is a mechanistic probe for separating RNA/DNA structure effects, channel blockade, and biological-system confounding. This guide connects molecular assay design with microbiome and immune-model interpretation.

• HyperScribe™ K1066: mRNA Synthesis Kit II

  2026-10-01

  This scenario-based guide explains how HyperScribe™ All in One mRNA Synthesis Kit II (EZ Cap Reagent AG (3' OMe), T7, poly(A)) (SKU K1066) can be incorporated into mRNA workflows supporting cell viability, proliferation, and cytotoxicity assays. It emphasizes appropriate controls, interpretation limits, protocol documentation, and practical vendor-selection criteria without overstating product-specific performance data.

• Cannabidiol, FAAH, and Affective Orofacial Pain

  2026-10-01

  A 2026 Brain Research Bulletin study shows that cannabidiol reduces both inflammatory orofacial nociception and pain-associated affective and cognitive abnormalities in mice. Its experiments connect peripheral CB2-linked anti-inflammatory effects, central CB1-associated endocannabinoid changes, and normalization of serotonin activity in the central amygdala, providing a multidimensional framework for pain research.

• Regorafenib: From Kinase Breadth to RRM2 Biology

  2026-09-30

  Regorafenib (BAY 73-4506) is more than a broad-spectrum kinase tool: emerging melanoma data connect its multikinase activity to RRM2 reduction and ERK/E2F3 signaling. This thought-leadership guide translates that mechanistic insight into practical strategies for angiogenesis research, cancer biology research, and translational oncology workflows.

• Carbapenemase Transmission in Guangdong CREC

  2026-09-30

  Chen and colleagues integrated carbapenemase gene detection, plasmid localization, conjugation testing, antimicrobial susceptibility profiling, mobile-element analysis, and ERIC-PCR to investigate carbapenem-resistant Enterobacter cloacae across eight teaching hospitals. The study identifies plasmid-associated blaNDM-1, extensive horizontal transfer potential, and hospital-spanning genotypes as important priorities for resistance surveillance and infection-control research.

• Neomycin sulfate for RNA/DNA Research Workflows

  2026-09-29

  Neomycin sulfate is an aminoglycoside antibiotic that functions as a versatile probe for RNA folding, DNA triplex stabilization, viral RNA recognition, and ion-channel gating. This workflow-focused guide shows how to build concentration screens, connect molecular readouts with microbiome and immune assays, and troubleshoot solubility, specificity, and experimental-design risks.

• Lithium, Exosomal Wnt10a, and Bone Regeneration

  2026-09-29

  The 2024 ACS Applied Materials & Interfaces study shows that lithium enhances BMSC osteogenesis by increasing Rab11a-associated exosomal Wnt10a secretion and activating the Wnt/β-catenin signaling pathway. Its comparison of lithium-engineered exosomes and GelMA hydrogels provides a mechanistic and materials-based framework for developing cell-free strategies for bone repair.

• Laminin (925-933) for ECM Assays

  2026-09-28

  Laminin (925-933) is a defined Laminin B1 chain peptide for separating receptor-mediated adhesion from the structural complexity of full-length laminin. This guide translates its validated attachment and chemotaxis behavior into practical 2D assays and carefully bounded exploratory workflows for ECM-supported islet organoid research.

• Dhx9 Shapes TH17 Differentiation and Autoimmunity

  2026-09-28

  Su et al. identify the nuclear helicase Dhx9 as a chromatin-level regulator that helps establish the TH17 transcriptional program, linking IL-6–STAT3 signaling to accessibility and transcription-factor binding at Rorc and Il17. T-cell-specific Dhx9 deletion reduced TH17 differentiation and autoimmune disease severity in mouse models, while punicalagin provided preliminary pharmacological evidence for targeting this pathway.

• Cisplatin Workflows for Cancer Research

  2026-09-27

  Build reliable Cisplatin experiments around fresh preparation, matched vehicle controls, and readouts that connect DNA damage with cell fate. A resistance-focused lung cancer study also offers a useful framework for comparing free drug with enzyme-responsive, shRNA-enabled delivery—without confusing a delivery platform with the compound itself.

• PYR-41 as a Probe of Ubiquitin-Dependent Signaling

  2026-09-26

  PYR-41, an inhibitor of Ubiquitin-Activating Enzyme E1, can help researchers test how ubiquitin activation shapes inflammatory signaling and protein stability. This article connects its strengths and limitations to recent findings on CD40–STING signaling in esophageal cancer, with practical guidance for designing interpretable experiments.

8618 records 1/575 page Next 12345 下5页 Last page